Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Liu G, Huang X, Cui X, Zhang J, Wei L, Ni R, Lu C.

Med Oncol. 2013;30(3):537. doi: 10.1007/s12032-013-0537-4. Epub 2013 May 22.

PMID:
23696020
2.

Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma.

Lu C, Liu G, Cui X, Zhang J, Wei L, Wang Y, Yang X, Liu Y, Cong X, Lv L, Ni R, Huang X.

Pathol Oncol Res. 2014 Jan;20(1):51-60. doi: 10.1007/s12253-013-9657-6. Epub 2013 Jul 10.

PMID:
23839012
3.

Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.

Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y, Liu Q.

Mol Cancer. 2014 May 17;13:110. doi: 10.1186/1476-4598-13-110.

4.

Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.

Chang R, Wei L, Lu Y, Cui X, Lu C, Liu L, Jiang D, Xiong Y, Wang G, Wan C, Qian H.

J Mol Histol. 2015 Feb;46(1):45-56. doi: 10.1007/s10735-014-9596-x. Epub 2014 Oct 14.

PMID:
25311764
5.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567
6.

Expression and prognostic role of SKIP in human breast carcinoma.

Liu X, Ni Q, Xu J, Sheng C, Wang Q, Chen J, Yang S, Wang H.

J Mol Histol. 2014 Apr;45(2):169-80. doi: 10.1007/s10735-013-9546-z. Epub 2013 Oct 23.

PMID:
24150787
7.

SKIP expression is correlated with clinical prognosis in patients with bladder cancer.

Wang L, Zhang M, Wu Y, Cheng C, Huang Y, Shi Z, Huang H.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1695-701. eCollection 2014.

8.

High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.

Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.

PMID:
22965687
9.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
10.

Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.

Huang X, Liu F, Zhu C, Cai J, Wang H, Wang X, He S, Liu C, Yao L, Ding Z, Zhang Y, Zhang T.

Dig Dis Sci. 2014 Apr;59(4):795-806. doi: 10.1007/s10620-013-2969-2. Epub 2013 Dec 25.

11.

Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.

Huang X, Wang X, Cheng C, Cai J, He S, Wang H, Liu F, Zhu C, Ding Z, Huang X, Zhang T, Zhang Y.

APMIS. 2014 Nov;122(11):1070-9. doi: 10.1111/apm.12258. Epub 2014 May 26.

PMID:
24862099
12.

Clinical and biological significance of never in mitosis gene A-related kinase 6 (NEK6) expression in hepatic cell cancer.

Cao X, Xia Y, Yang J, Jiang J, Chen L, Ni R, Li L, Gu Z.

Pathol Oncol Res. 2012 Apr;18(2):201-7. doi: 10.1007/s12253-011-9429-0. Epub 2011 Jul 5.

PMID:
21725899
13.

Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.

Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A.

Exp Mol Pathol. 2009 Dec;87(3):167-72. doi: 10.1016/j.yexmp.2009.07.011. Epub 2009 Aug 15.

PMID:
19686732
14.

Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.

Qiu H, Zhang X, Ni W, Shi W, Fan H, Xu J, Chen Y, Ni R, Tao T.

Dig Dis Sci. 2016 Mar;61(3):795-805. doi: 10.1007/s10620-015-3937-9. Epub 2015 Nov 9.

PMID:
26553251
15.

High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma.

Hu B, Jiang D, Chen Y, Wei L, Zhang S, Zhao F, Ni R, Lu C, Wan C.

Tumour Biol. 2015 Apr;36(4):2569-81. doi: 10.1007/s13277-014-2873-1. Epub 2015 Feb 11.

PMID:
25874485
16.

Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma.

Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J, He S, Lv L, Cong X, Liu G, Zhang Y, Ni R.

Pathol Res Pract. 2014 Mar;210(3):169-75. doi: 10.1016/j.prp.2013.11.011. Epub 2013 Dec 5.

PMID:
24359721
17.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

18.

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.

World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

19.

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.

J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5.

PMID:
26438629
20.

Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.

Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5645-54. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk